Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 1
1964 1
1981 4
1982 5
1983 1
1984 5
1985 2
1986 3
1987 3
1988 2
1989 4
1990 8
1991 1
1992 2
1993 7
1994 4
1995 2
1996 5
1997 6
1998 5
1999 4
2000 6
2001 7
2002 4
2003 1
2004 2
2005 6
2006 2
2007 7
2008 5
2009 10
2010 17
2011 15
2012 9
2013 12
2014 12
2015 12
2016 15
2017 11
2018 5
2019 3
2020 7
2021 4
2022 6
2023 5
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Betibeglogene Autotemcel Gene Therapy for Non-β00 Genotype β-Thalassemia.
Locatelli F, Thompson AA, Kwiatkowski JL, Porter JB, Thrasher AJ, Hongeng S, Sauer MG, Thuret I, Lal A, Algeri M, Schneiderman J, Olson TS, Carpenter B, Amrolia PJ, Anurathapan U, Schambach A, Chabannon C, Schmidt M, Labik I, Elliot H, Guo R, Asmal M, Colvin RA, Walters MC. Locatelli F, et al. Among authors: porter jb. N Engl J Med. 2022 Feb 3;386(5):415-427. doi: 10.1056/NEJMoa2113206. Epub 2021 Dec 11. N Engl J Med. 2022. PMID: 34891223 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Among authors: porter jb. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Iron Through the Prism of Haematology.
Porter JB. Porter JB. Br J Haematol. 2020 Nov;191(4):587-592. doi: 10.1111/bjh.17164. Br J Haematol. 2020. PMID: 33190267 Review.
Deferoxamine pharmacokinetics.
Porter JB. Porter JB. Semin Hematol. 2001 Jan;38(1 Suppl 1):63-8. doi: 10.1016/s0037-1963(01)90061-7. Semin Hematol. 2001. PMID: 11206963 Review.
Deferasirox: an update.
Porter JB. Porter JB. Hemoglobin. 2009;33 Suppl 1:S70-5. doi: 10.3109/03630260903347146. Hemoglobin. 2009. PMID: 20001635 Review.
TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia.
Musallam KM, Cappellini MD, Porter JB, Farmakis D, Eleftheriou A, Angastiniotis M, Taher AT. Musallam KM, et al. Among authors: porter jb. Hemasphere. 2025 Mar 5;9(3):e70095. doi: 10.1002/hem3.70095. eCollection 2025 Mar. Hemasphere. 2025. PMID: 40045934 Free PMC article. No abstract available.
IRON OVERLOAD AND CHELATION.
Porter JB, Wood JC, Coates TD. Porter JB, et al. In: Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, editors. Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT) [Internet]. 5th edition. Nicosia, Cyprus: Thalassaemia International Federation; 2025. Chapter 3. In: Taher AT, Farmakis D, Porter JB, Cappellini MD, Musallam KM, editors. Guidelines for the Management of Transfusion-Dependent β-Thalassaemia (TDT) [Internet]. 5th edition. Nicosia, Cyprus: Thalassaemia International Federation; 2025. Chapter 3. PMID: 40367265 Free Books & Documents. Review. No abstract available.
The pathophysiology of transfusional iron overload.
Porter JB, Garbowski M. Porter JB, et al. Hematol Oncol Clin North Am. 2014 Aug;28(4):683-701, vi. doi: 10.1016/j.hoc.2014.04.003. Hematol Oncol Clin North Am. 2014. PMID: 25064708 Review.
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.
Taher AT, Viprakasit V, Kattamis A, Perrotta S, Ricchi P, Porter JB, Coates TD, Forni GL, Musallam KM, Esposito O, Pilot R, Kuo WL, Lai Y, Reverte M, Wei R, Moro Bueno L, Cappellini MD. Taher AT, et al. Among authors: porter jb. Blood Adv. 2025 Aug 28:bloodadvances.2025016554. doi: 10.1182/bloodadvances.2025016554. Online ahead of print. Blood Adv. 2025. PMID: 40875596
236 results